Welcome to our dedicated page for Veeva Systems news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Systems stock.
Veeva Systems Inc. (NYSE: VEEV) is a global leader in cloud-based software solutions specifically tailored for the life sciences industry. Headquartered in the San Francisco Bay Area, Veeva Systems provides innovative technology that helps pharmaceutical and biotech companies streamline their operations, ensure compliance, and bring products to market faster. Veeva's product offerings address key operational and regulatory needs, ranging from customer relationship management (CRM) to content management and data analytics.
Two of the company's flagship products include Veeva CRM and Veeva Vault. Veeva CRM is designed for companies with a salesforce, providing tools to manage customer interactions more efficiently. Meanwhile, Veeva Vault is a versatile content management platform that supports various functions such as clinical trials, regulatory submissions, and quality management within life sciences companies.
Veeva serves a diverse customer base, ranging from emerging biotechs to some of the world's largest pharmaceutical companies. Its commitment to product excellence, customer success, and continuous innovation is evident as Veeva frequently updates its offerings to meet the evolving needs of the industry. Recently, Veeva announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications to streamline clinical execution and improve regulatory management in its animal health business unit.
Another notable achievement for Veeva was the launch of the Veeva AI Partner Program, designed to help partners integrate Generative AI solutions seamlessly with Veeva Vault applications. This initiative highlights Veeva's ongoing efforts to leverage advanced technologies to enhance its product ecosystem. Furthermore, the introduction of Veeva Vault CRM Campaign Manager aims to simplify and speed up non-personal promotion to healthcare professionals, ensuring consistent and compliant marketing efforts.
Financially, Veeva Systems has shown strong performance with its fiscal year 2024 results reflecting robust growth. The company continues to invest in its innovation engine and strategic partnerships, setting the stage for sustained, profitable growth. Veeva's recent financial outlook for fiscal year 2025 and first quarter results for 2024 further underline its market leadership and operational excellence.
For more information about Veeva Systems, its products, and latest updates, visit www.veeva.com.
Veeva Systems (NYSE: VEEV) released its Veeva Pulse Field Trends Report, revealing that U.S. healthcare professional (HCP) access now averages 60%, with key specialties nearing 80%. The report highlights that over 50% of accessible HCPs engage via video, generating 3x promotional response compared to in-person only. Additionally, half of accessible HCPs limit engagements to three companies or less. Companies can leverage this data to optimize field strategies and enhance engagement efficiency, ultimately driving better outcomes in the biopharma industry.
Veeva Systems (NYSE: VEEV) will announce its third quarter financial results on December 1, 2022, following the close of the market. The results will cover the period ending October 31, 2022. A conference call and webcast will take place at 2:00 p.m. PT (5:00 p.m. ET) the same day to discuss these results. Investors can access prepared remarks on Veeva's investor relations website at 1:05 p.m. PT (4:05 p.m. ET). A replay of the webcast will be available afterward.
Veeva Systems (NYSE: VEEV) has announced a ten-year strategic partnership with Merck (NYSE: MRK), building upon their existing 12-year collaboration. The agreement entails Merck adopting a Veeva-first approach for new software and data solutions, aimed at reducing operational costs and enhancing patient and healthcare professional experiences. Veeva will offer a strategic pricing model and seek Merck's input on product development. This partnership is designed to accelerate Merck's digital transformation and improve efficiency in utilizing Veeva’s integrated platform.
Veeva Systems has launched Veeva Vault CRM for Medtech, a new unified CRM and content management application tailored for medtech sales teams and medical affairs professionals. This solution allows medtech companies to efficiently manage customer relationships and content without extensive customizations. Key features include inventory management, surgical case management, and stakeholder navigation. This application aims to enhance collaboration and streamline business processes across commercial and medical teams.
Veeva Systems (NYSE: VEEV) announced the launch of Veeva CDB, a new solution designed to streamline clinical data management by aggregating and transforming data from various sources. This platform aims to reduce complexity and costs in clinical trial data handling, allowing for centralized data query resolution and improved trial execution speed. Veeva CDB has supported over 100 trials, enhancing data visibility and enabling faster decision-making. It also introduces a Data Provider Program to standardize data delivery among sponsors, CROs, and providers.
Veeva Systems (NYSE: VEEV) unveiled Veeva ePRO on October 18, 2022, enhancing patient-centric digital trials. This application streamlines patient assessments via mobile devices and web browsers, enabling sponsors and research sites to access real-time data. Addressing challenges like lengthy trial participation and redundant data entry, Veeva ePRO improves patient experience. Integrated within the Veeva Vault Clinical Suite, it facilitates seamless communication and tracking, offering benefits for both patients and trial sponsors.
On October 17, 2022, Veeva Systems (NYSE: VEEV) announced that 40 contract research organizations (CROs), including four of the top six global CROs, have adopted the Veeva Vault CTMS to enhance clinical trial efficiency. This solution is now used by over 120 sponsors, including nine of the top 20 pharmaceutical companies, establishing it as the industry leader in clinical trial management. The Vault CTMS provides a comprehensive view of trial metrics, improving collaboration and study performance, which is essential for accelerating trial processes.
Veeva Systems (NYSE: VEEV) announced the launch of two new applications, Link SiteBase and Link TrialBase, aimed at enhancing clinical trial design and site selection. Set for release in April and October 2023, respectively, Link SiteBase helps identify and rank research sites, while Link TrialBase provides critical clinical trial intelligence. The innovations are designed to address challenges in trial execution, such as intense competition and protocol complexity, delivering comprehensive data to speed up trial outcomes.
Veeva Systems (NYSE: VEEV) announced that over 350 companies are leveraging its Veeva Vault RIM Suite applications to enhance regulatory processes. In the past year, more than 65 emerging biotechs adopted these solutions to improve submission planning and compliance with evolving regulations. Notable advancements include Active Dossier management, label change tracking, and non-eCTD electronic publishing. A top 20 pharma streamlined 19 million data points through the platform, reducing SOPs by 90%. The suite's new features aim to accelerate time to market for submissions.
Veeva Systems (NYSE: VEEV) will host a virtual financial analyst and investor day on November 3, 2022. The event starts at 9:00 a.m. PT and ends around 11:00 a.m. PT. Presentations will be broadcast live on the company's investor relations website, with an archived link available post-event. Interested participants can register online through the investor relations site. Veeva leads in cloud software for the life sciences sector, serving over 1,000 clients.
FAQ
What is the current stock price of Veeva Systems (VEEV)?
What is the market cap of Veeva Systems (VEEV)?
What does Veeva Systems Inc. do?
Where is Veeva Systems Inc. headquartered?
What are Veeva's main products?
Who are Veeva Systems' customers?
What recent partnerships has Veeva announced?
What is the Veeva AI Partner Program?
How has Veeva performed financially recently?
What is Veeva Vault CRM Campaign Manager?
What industry does Veeva Systems primarily serve?
How does Veeva contribute to the life sciences industry?
